Mitch Keamy is an anesthesiologist in Las Vegas Nevada
Andy Kofke is a Professor of Neuro-anesthesiology and Critical Care at the University of Pennslvania
Mike O'Connor is Professor of Anesthesiology and Critical Care at the University of Chicago
Rob Dean is a cardiac anesthesiologist in Grand Rapids Michigan, with extensive experience in O.R. administration.
I was just wondering:
Everyone knows that there have been significant problems with quality control in the manufacture of heparin, especially in foreign plants (be certain: there have been problems in the past with US manufacture as well).
I am the only person who wonders whether the epidemic of HIT for the past decade or so might be in part a consequence of lax quality control in the manufacture of heparin? Will it subside with additional scrutiny of its' manufacturing?
Answers:
Almost certainly not.
Maybe.
